To prove that the activation of primary human lymphocytes in TICS was dependent on antigens presented by TNBC cancer cells, we interrupted antigen presentation to CD8+ T cells by either genetic deletion of the B2M gene in cancer cells or by using a blocking antibody against HLA-ABC (Supplementary Fig. 1a). This evidence concerns the gene B2M and cancer.